Ad |
adenovirus |
AR |
antigenic region |
AS |
antigenic site |
(b)nAb |
(broadly) neutralizing antibody |
CD |
cluster of differentiation |
ChAd |
chimpanzee adenovirus |
CTLA4 |
cytotoxic T lymphocyte antigen 4 |
DAA |
direct-acting antivirals |
E1E2 |
envelope 1/2 protein |
ERAP |
endoplasmic reticulum aminopeptidase |
HBsAg |
Hepatitis B surface antigen |
HBV |
hepatitis B virus |
HCC |
hepatocellular carcinoma |
HCV |
hepatitis C virus |
HLA |
human leukocyte antigen |
HMG |
high mobility group |
HVR |
hypervariable region |
IFN |
interferon |
MVA |
modified vaccinia Ankara |
NS |
non-structural (protein) |
PD-1 |
programmed death 1 |
PWID |
people who inject drugs |
TCF |
T cell factor |
Tfh |
T follicular helper (cell) |
TIGIT |
T-cell immunoreceptor with Ig and ITIM domains |
TNF |
tumor necrosis factor |
TOX |
thymocyte selection-associated HMG box |